IMO, better than going to individual small companies in drug/research area. ARKG has full clout on those companies with 10% holding, they can dictate terms, appoint directors…etc.
Make sure you draw EWT on ARKG and get into buying position.
IMO, better than going to individual small companies in drug/research area. ARKG has full clout on those companies with 10% holding, they can dictate terms, appoint directors…etc.
Make sure you draw EWT on ARKG and get into buying position.